Loss to follow-up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South Africa

Trop Med Int Health. 2013 Apr;18(4):451-60. doi: 10.1111/tmi.12072. Epub 2013 Feb 3.

Abstract

Objective: HIV-positive pregnant women are at heightened risk of becoming lost to follow-up (LTFU) from HIV care. We examined LTFU before and after delivery among pregnant women newly diagnosed with HIV.

Methods: Observational cohort study of all pregnant women ≥18 years (N = 300) testing HIV positive for the first time at their first ANC visit between January and June 2010, at a primary healthcare clinic in Johannesburg, South Africa. Women (n = 27) whose delivery date could not be determined were excluded.

Results: Median (IQR) gestation at HIV testing was 26 weeks (21-30). Ninety-eight per cent received AZT prophylaxis, usually started at the first ANC visit. Of 139 (51.3%) patients who were ART eligible, 66.9% (95% CI 58.8-74.3%) initiated ART prior to delivery; median (IQR) ART duration pre-delivery was 9.5 weeks (5.1-14.2). Among ART-eligible patients, 40.5% (32.3-49.0%) were cumulatively retained through 6 months on ART. Of those ART-ineligible patients at HIV testing, only 22.6% (95% CI 15.9-30.6%) completed CD4 staging and returned for a repeat CD4 test after delivery. LTFU (≥1 month late for last scheduled visit) before delivery was 20.5% (95% CI 16.0-25.6%) and, among those still in care, 47.9% (95% CI 41.2-54.6%) within 6 months after delivery. Overall, 57.5% (95% CI 51.6-63.3%) were lost between HIV testing and 6 months post-delivery.

Conclusions: Our findings highlight the challenge of continuity of care among HIV-positive pregnant women attending antenatal services, particularly those ineligible for ART.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Anti-Retroviral Agents / therapeutic use
  • CD4 Lymphocyte Count
  • Cohort Studies
  • Continuity of Patient Care*
  • Delivery, Obstetric
  • Female
  • Gestational Age
  • HIV Seropositivity / complications*
  • HIV Seropositivity / drug therapy
  • Humans
  • Infectious Disease Transmission, Vertical / prevention & control
  • Lost to Follow-Up*
  • Patient Acceptance of Health Care / psychology
  • Patient Compliance / psychology
  • Postnatal Care / psychology*
  • Pregnancy
  • Pregnancy Complications, Infectious*
  • Prenatal Care / psychology*
  • South Africa
  • Young Adult

Substances

  • Anti-Retroviral Agents